vs

Side-by-side financial comparison of Alset Inc. (AEI) and Ovid Therapeutics Inc. (OVID). Click either name above to swap in a different company.

Alset Inc. is the larger business by last-quarter revenue ($1.3M vs $718.0K, roughly 1.8× Ovid Therapeutics Inc.). On growth, Ovid Therapeutics Inc. posted the faster year-over-year revenue change (844.7% vs -85.4%). Over the past eight quarters, Ovid Therapeutics Inc.'s revenue compounded faster (120.3% CAGR vs -53.7%).

Alset Global GmbH is an Austrian technology and engineering company based in Graz that specialises in hydrogen-based clean mobility products. Alset Global is known for developing a Hybrid Hydrogen internal combustion engine that can run on either pure petrol, pure hydrogen or a combination of both. This technology offers a sustainable and clean alternative to petrol-based internal combustion engines. The technology has been developed to create an alternative technology to meet new emission ta...

AEI vs OVID — Head-to-Head

Bigger by revenue
AEI
AEI
1.8× larger
AEI
$1.3M
$718.0K
OVID
Growing faster (revenue YoY)
OVID
OVID
+930.1% gap
OVID
844.7%
-85.4%
AEI
Faster 2-yr revenue CAGR
OVID
OVID
Annualised
OVID
120.3%
-53.7%
AEI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
AEI
AEI
OVID
OVID
Revenue
$1.3M
$718.0K
Net Profit
Gross Margin
35.2%
Operating Margin
Net Margin
Revenue YoY
-85.4%
844.7%
Net Profit YoY
-1491.5%
204.4%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AEI
AEI
OVID
OVID
Q4 25
$1.3M
$718.0K
Q3 25
$998.8K
$132.0K
Q2 25
$1.1M
$6.3M
Q1 25
$1.1M
$130.0K
Q4 24
$8.9M
$76.0K
Q3 24
$5.0M
$173.0K
Q2 24
$1.1M
$169.0K
Q1 24
$6.1M
$148.0K
Net Profit
AEI
AEI
OVID
OVID
Q4 25
Q3 25
$1.5M
$-12.2M
Q2 25
$-8.2M
$-4.7M
Q1 25
$-8.3M
$-10.2M
Q4 24
$2.3M
Q3 24
$1.7M
$-14.0M
Q2 24
$-1.2M
$8.5M
Q1 24
$-6.8M
$-11.7M
Gross Margin
AEI
AEI
OVID
OVID
Q4 25
35.2%
Q3 25
24.3%
Q2 25
23.3%
Q1 25
27.2%
Q4 24
51.4%
Q3 24
40.5%
Q2 24
26.4%
Q1 24
23.5%
Operating Margin
AEI
AEI
OVID
OVID
Q4 25
Q3 25
-258.2%
-9487.1%
Q2 25
-250.7%
-80.9%
Q1 25
-368.1%
-9653.8%
Q4 24
21.5%
Q3 24
-19.4%
-7645.1%
Q2 24
-249.3%
-12140.2%
Q1 24
-37.2%
-11768.2%
Net Margin
AEI
AEI
OVID
OVID
Q4 25
Q3 25
151.4%
-9210.6%
Q2 25
-748.1%
-74.7%
Q1 25
-780.1%
-7873.1%
Q4 24
26.0%
Q3 24
34.6%
-8096.0%
Q2 24
-109.9%
5042.0%
Q1 24
-111.2%
-7901.4%
EPS (diluted)
AEI
AEI
OVID
OVID
Q4 25
Q3 25
$0.05
Q2 25
$-0.71
Q1 25
$-0.78
Q4 24
$0.24
Q3 24
$0.19
$-0.20
Q2 24
$-0.13
$0.12
Q1 24
$-0.73
$-0.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AEI
AEI
OVID
OVID
Cash + ST InvestmentsLiquidity on hand
$25.2M
$13.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$121.1M
$130.7M
Total Assets
$136.6M
$150.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AEI
AEI
OVID
OVID
Q4 25
$25.2M
$13.2M
Q3 25
$25.5M
$20.6M
Q2 25
$25.6M
$28.4M
Q1 25
$25.2M
$21.1M
Q4 24
$27.2M
$26.3M
Q3 24
$16.7M
$15.0M
Q2 24
$18.9M
$29.7M
Q1 24
$23.7M
$30.8M
Total Debt
AEI
AEI
OVID
OVID
Q4 25
Q3 25
Q2 25
Q1 25
$116.5K
Q4 24
$123.1K
Q3 24
$137.9K
Q2 24
$137.8K
Q1 24
$145.8K
Stockholders' Equity
AEI
AEI
OVID
OVID
Q4 25
$121.1M
$130.7M
Q3 25
$155.7M
$44.7M
Q2 25
$72.8M
$55.8M
Q1 25
$76.4M
$59.3M
Q4 24
$81.3M
$68.2M
Q3 24
$84.2M
$76.3M
Q2 24
$79.4M
$88.9M
Q1 24
$81.7M
$78.3M
Total Assets
AEI
AEI
OVID
OVID
Q4 25
$136.6M
$150.9M
Q3 25
$169.1M
$63.8M
Q2 25
$86.0M
$77.4M
Q1 25
$90.5M
$81.7M
Q4 24
$96.8M
$92.2M
Q3 24
$98.8M
$102.7M
Q2 24
$93.5M
$118.1M
Q1 24
$96.7M
$131.6M
Debt / Equity
AEI
AEI
OVID
OVID
Q4 25
Q3 25
Q2 25
Q1 25
0.00×
Q4 24
0.00×
Q3 24
0.00×
Q2 24
0.00×
Q1 24
0.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AEI
AEI
OVID
OVID
Operating Cash FlowLast quarter
$-5.9M
$-38.3M
Free Cash FlowOCF − Capex
$-6.1M
FCF MarginFCF / Revenue
-467.7%
Capex IntensityCapex / Revenue
13.4%
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-11.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AEI
AEI
OVID
OVID
Q4 25
$-5.9M
$-38.3M
Q3 25
$883.4K
$-12.9M
Q2 25
$-2.6M
$-4.8M
Q1 25
$-3.8M
$-10.3M
Q4 24
$5.2M
$-56.0M
Q3 24
$-2.9M
$-15.0M
Q2 24
$-4.4M
$-14.3M
Q1 24
$-1.5M
$-16.7M
Free Cash Flow
AEI
AEI
OVID
OVID
Q4 25
$-6.1M
Q3 25
$822.4K
Q2 25
$-2.7M
Q1 25
$-3.8M
Q4 24
$5.1M
$-56.0M
Q3 24
$-2.9M
$-15.0M
Q2 24
$-4.4M
$-14.3M
Q1 24
$-1.5M
$-16.7M
FCF Margin
AEI
AEI
OVID
OVID
Q4 25
-467.7%
Q3 25
82.3%
Q2 25
-245.9%
Q1 25
-357.3%
Q4 24
56.5%
-73719.7%
Q3 24
-58.2%
-8676.9%
Q2 24
-392.3%
-8455.0%
Q1 24
-24.8%
-11287.2%
Capex Intensity
AEI
AEI
OVID
OVID
Q4 25
13.4%
0.0%
Q3 25
6.1%
0.0%
Q2 25
7.6%
0.0%
Q1 25
5.7%
0.0%
Q4 24
1.1%
93.4%
Q3 24
0.6%
2.3%
Q2 24
3.0%
20.1%
Q1 24
0.0%
12.8%
Cash Conversion
AEI
AEI
OVID
OVID
Q4 25
Q3 25
0.58×
Q2 25
Q1 25
Q4 24
2.22×
Q3 24
-1.66×
Q2 24
-1.67×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons